Table 2 Comorbidities and blood tests results in patients with and without COPD
COPD | No (n = 776,764; 97%) | Yes (n = 24,135; 3%) | Dif | Total (n = 800,899; 100%) | p | |||
|---|---|---|---|---|---|---|---|---|
N | n (%) | N | n (%) | N | n (%) | |||
DM2 (Y) | 776,764 | 98,932 (12.7%) | 24,135 | 6453 (26.7%) | 14.0% | 800,899 | 105,385 (13.2%) | < 0.001 |
Prediabetes (Y) | 776,764 | 29,232 (3.8%) | 24,135 | 1588 (6.6%) | 2.8% | 800,899 | 30,820 (3.8%) | < 0.001 |
Anaemia (Y) | 776,764 | 60,875 (7.8%) | 24,135 | 3160 (13.1%) | 5.3% | 800,899 | 64,035 (8%) | < 0.001 |
Ischaemic Cardiomyopathy (Y) | 776,764 | 18,812 (2.4%) | 24,135 | 2134 (8.8%) | 6.4% | 800,899 | 20,946 (2.6%) | < 0.001 |
Dyslipidaemia (Y) | 776,764 | 250,256 (32.2%) | 24,135 | 11,039 (45.7%) | 13.5% | 800,899 | 261,295 (32.6%) | < 0.001 |
AF (Y) | 776,764 | 24,423 (3.1%) | 24,135 | 2852 (11.8%) | 8.7% | 800,899 | 27,275 (3.4%) | < 0.001 |
Hypertension (Y) | 776,764 | 262,190 (33.8%) | 24,135 | 14,256 (59.1%) | 25.3% | 800,899 | 276,446 (34.5%) | < 0.001 |
Chronic kidney failure (Y) | 776,764 | 29,259 (3.8%) | 24,135 | 2823 (11.7%) | 7.9% | 800,899 | 32,082 (4%) | < 0.001 |
Heart Failure (Y) | 776,764 | 13,253 (1.7%) | 24,135 | 2672 (11.1%) | 9.4% | 800,899 | 15,925 (2%) | < 0.001 |
Stroke (Y) | 776,764 | 22,330 (2.9%) | 24,135 | 1944 (8.1%) | 5.2% | 800,899 | 24,274 (3%) | < 0.001 |
Lung Cancer (Y) | 776,764 | 1740 (0.2%) | 24,135 | 552 (2.3%) | 2.1% | 800,899 | 2292 (0.3%) | < 0.001 |
Fibrinogen | 59,544 | 375.2 ± 94.3 | 3556 | 407.2 ± 105.7 | 32.01 | 63,100 | 377 ± 95.3 | < 0.001 |
C-reactive protein | 56,406 | 8.3 ± 20.9 | 3367 | 15.3 ± 32.5 | 7.05 | 59,773 | 8.7 ± 21.7 | < 0.001 |